stockrow
Friday 6 November 2026
Export ALC’s income statement to Excel — free account
Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
76.45
0.86
−1.11%
Follow ALC
Alert me
Alcon (ALC) Net income
Alcon's net income for fiscal 2025 was $980.0M, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $643.0M. Over the past ten years it has ranged from −$656.0M (fiscal 2019) to $1.0B (fiscal 2024); the current reading is higher than 90% of that period. Alcon ranks 5th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $980.0M | (3.73%) |
| FY2024 | $1.0B | 4.52% |
| FY2023 | $974.0M | 190.75% |
| FY2022 | $335.0M | (10.90%) |
| FY2021 | $376.0M | — |
| FY2020 | −$531.0M | — |
| FY2019 | −$656.0M | — |
| FY2018 | −$227.0M | — |
| FY2017 | $0.00 | — |
| FY2016 | −$163.7M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $0.00 | — |
| Mar 2026 | $189.0M | (12.90%) |
| Dec 2025 | $217.0M | (8.44%) |
| Sep 2025 | $237.0M | 34.66% |
| 29 more quarters | Free account |
Against its own ten years
Low −$656.0M
High $1.0B
Ten-year median
$167.5M
Current reading's percentile
90
Net income against peers
| Company | Net income |
|---|---|
| MDLN Medline Inc. compare | $1.9B |
| RMD ResMed Inc. compare | $1.6B |
| BDX Becton, Dickinson and Company compare | $942.0M |
| ALC Alcon | $643.0M |
| WST West Pharmaceutical Services, Inc. compare | $638.9M |
| COO The Cooper Companies, Inc. compare | $570.3M |
| ALGN Align Technology, Inc. compare | $413.6M |
| SOLV Solventum Corporation compare | $156.0M |
| BAX Baxter International Inc. compare | −$723.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ALC
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement